Published in
BioMed Central, BMC Cardiovascular Disorders, 1(16), 2016
DOI: 10.1186/s12872-016-0405-1
Links
- BioMed Central | PDF
- ORCID
- ORCID
- [www.producao.usp.br] | PDF
- [www.biomedcentral.com] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range – study protocol for a randomized controlled trial
Journal article published in 2016 by
Leiliane Rodrigues Marcatto,
Luciana Sacilotto Fernandes,
Luciana Sacilotto,
Carolina Tosin Bueno,
Mirella Facin,
Strunz Celia Maria Cassaro Strunz,
Francisco Carlos Costa Darrieux 
,
Mauricio Ibrahim Scanavacca ,
Jose Eduardo Krieger,
Alexandre Costa Pereira,
Paulo Caleb Júnior de Lima Santos,
Paulo Caleb Junior Lima Santos
,
Mauricio Ibrahim Scanavacca ,
Jose Eduardo Krieger,
Alexandre Costa Pereira,
Paulo Caleb Júnior de Lima Santos,
Paulo Caleb Junior Lima Santos
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Abstract Background Time in therapeutic range (TTR) is a measurement of quality of warfarin therapy and lower TTR values (